Dr Lorusso obtained her degree in Medicine and Surgery in 1995, her residency in Obstetrics and Gynecology in 1999 and her PhD in Obstetrics and Gynecology in 2003. She is currently Associate Professor of Obstetrics and Gynecology at the Catholic University of Rome and responsible for clinical research at Fondazione Policlinico Gemelli IRCCS.
Dr Lorusso has been an active member of the MITO Group since 1998, she is past chair of the Clinical Trials Committee and chair of the International Relationship Committee since 2014. With her support, the scientific production of the group has spread to high international relevance, producing several studies published in high level peer-reviewed journals and laying the groundwork for a new standard of care in Gynecological Oncology. She is an active member of the European Network of Gynaecological Oncological Trial groups (ENGOT) where she leads the Gynecological Cancer Academy (since 2020). Dr Lorusso is a member of the Board of Directors of the Gynecologic Cancer InterGroup (GCIG) where she is past chair of the Endometrial Cancer Committee and the Nomination and Meeting Committee. Currently, she is a member of the ESGO Council and scientific coordinator of the ESMO Gynaecological Cancers Congress. She is involved in preclinical and clinical research in gynecological cancer, and she is the author of more than 250 papers on gynecological cancers. Her work has hugely contributed to improving the quality of care and clinical outcome and to reducing the toxicity of treatments in women with advanced gynecological malignancies.
Domenica Lorusso was the Gynaecological Cancers Track Chair of the ESMO 2017 Congress, which took place in Madrid, Spain (8-12 September 2017).